LRCX · Bull vs Bear

The case for and the case against LAM RESEARCH CORPORATION, each point drawn from public SEC filings — who’s buying, the red flags, and the health score. No opinion, no price call. Read both sides, then pick yours.

🐂 the bull case // 6

Institutions hold it

Held by 6 of the 13F institutional filers we track.

SEC 13F →

Strong financial strength

Piotroski F 8/9

SEC XBRL

Strong bankruptcy safety

Altman Z: safe zone

SEC XBRL

Strong cash position

self-funding

SEC XBRL

Strong price momentum

+53.5% vs 200-day

SEC XBRL

Balance sheet in the safe zone

Altman Z-Score puts the company clear of financial-distress territory.

SEC XBRL

🐻 the bear case // 1

Insiders are selling

11 insider sales recently with no offsetting open-market buys.

SEC Form 4 →

where do you land on LRCX?

Saved on this device. Your call, from the evidence above — not a recommendation.

the scoreboard behind both sides

Health A · 89/100Piotroski F 8/9Altman Z: safeBeneish M: clear

Full health score →LRCX workspace →Do they need money? →

Educational only — not financial adviceand never a recommendation to buy or sell. Both sides are built from public SEC filings (Form 4, STOCK Act, 13F, XBRL financials), which lag 40–90 days; absence of a red flag is not a clean bill of health.